Market Overview:
The global orbital atherectomy device market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of peripheral vascular diseases, technological advancements in orbital atherectomy devices, and rising demand for minimally invasive procedures. Based on type, the global orbital atherectomy device market can be segmented into peripheral vascular, cardiovascular, and neurovascular devices. Peripheral vascular devices are expected to account for the largest share of the global market in 2018 owing to their growing use in endovascular procedures for treating conditions such as atherosclerosis and aneurysms. Cardiovascular devices are also expected to witness significant growth during the forecast period due to their increasing use in percutaneous coronary interventions (PCI) and other cardiac surgeries. Neurovascular devices are anticipated to experience high growth rates due to their expanding use in stroke treatments.
Product Definition:
An orbital atherectomy device is a medical device used to remove plaque from the arteries. The importance of this device is that it can help to improve blood flow and reduce the risk of heart attack or stroke.
Peripheral Vascular:
Peripheral vascular is a blood vessel that supplies oxygen-rich blood to the tissues and organs in the peripheral part of the body. The main function of this vessel is to collect blood from the capillaries and deliver it to nourishment centers, like lungs, skin, kidneys etc.
Cardiovascular:
The cardiovascular system is a group of organs that pumps blood to the tissues and helps in maintaining the blood pressure. The heart is one of the major components of cardiovascular system, it contracts and expands according to requirements. The other parts are arteries, veins, lungs, and pump (brin).
Application Insights:
The hospitals and surgical centers segment dominated the global orbital atherectomy device market in 2017. This can be attributed to factors such as availability of advanced healthcare facilities, highly skilled medical personnel, and a large number of patients suffering from various eye diseases. Orbital artery embolization is an effective treatment for ocular hypertension that reduces the risk of visual impairment due to blood vessel disorders. Thus, this procedure is widely adopted in hospitals & surgical centers across the globe owing to its benefits over conventional methods such as catheter angioplasty or surgery.
The ambulatory care centers segment is expected to expand at a lucrative CAGR during the forecast period owing to factors such as increasing awareness about OAVDs among general practitioners (GPs) and surgeons along with rising adoption of these devices by primary healthcare providers (PHCs).
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in the prevalence of cardiovascular and neurovascular diseases, increasing geriatric population, and high adoption of advanced technologies. Moreover, growing number of research studies conducted to determine the efficiency and safety of ORAD is also expected to drive growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to rising healthcare expenditure by governments as well as private sectors coupled with improving infrastructure facilities for treatment & diagnosis. In addition, increasing awareness about atherectomy procedures along with growing medical tourism industry will boost demand further over next eight years.
Growth Factors:
- Increasing incidence of atherosclerosis and other cardiovascular diseases
- Growing geriatric population
- Rising awareness about the benefits of early intervention for treating atherosclerosis and other cardiovascular diseases
- Technological advancements in orbital atherectomy devices that make them more efficient and safe to use
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Orbital Atherectomy Device Market Research Report
By Type
Peripheral Vascular, Cardiovascular, Neurovascular
By Application
Hospitals & Surgical Centers, Ambulatory Care Centers, Research Laboratories & Academic Institutes
By Companies
Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), Cardiovascular Systems (US), Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), Avinger (US)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Orbital Atherectomy Device Market Report Segments:
The global Orbital Atherectomy Device market is segmented on the basis of:
Types
Peripheral Vascular, Cardiovascular, Neurovascular
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals & Surgical Centers, Ambulatory Care Centers, Research Laboratories & Academic Institutes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic (Ireland)
- Philips (Netherlands)
- Boston Scientific (US)
- Cardiovascular Systems (US)
- Straub Medical (Switzerland)
- BIOTRONIK (Netherlands)
- C.R. Bard (US)
- Avinger (US)
Highlights of The Orbital Atherectomy Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Peripheral Vascular
- Cardiovascular
- Neurovascular
- By Application:
- Hospitals & Surgical Centers
- Ambulatory Care Centers
- Research Laboratories & Academic Institutes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Orbital Atherectomy Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Orbital Atherectomy Device is a surgical instrument that uses a small cutting wheel to remove material from inside the orbit (eye socket). This procedure is used to treat certain types of eye diseases, including glaucoma and cataracts.
Some of the key players operating in the orbital atherectomy device market are Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), Cardiovascular Systems (US), Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), Avinger (US).
The orbital atherectomy device market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Orbital Atherectomy Device Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Orbital Atherectomy Device Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Orbital Atherectomy Device Market - Supply Chain
4.5. Global Orbital Atherectomy Device Market Forecast
4.5.1. Orbital Atherectomy Device Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Orbital Atherectomy Device Market Size (000 Units) and Y-o-Y Growth
4.5.3. Orbital Atherectomy Device Market Absolute $ Opportunity
5. Global Orbital Atherectomy Device Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Orbital Atherectomy Device Market Size and Volume Forecast by Type
5.3.1. Peripheral Vascular
5.3.2. Cardiovascular
5.3.3. Neurovascular
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Orbital Atherectomy Device Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Orbital Atherectomy Device Market Size and Volume Forecast by Application
6.3.1. Hospitals & Surgical Centers
6.3.2. Ambulatory Care Centers
6.3.3. Research Laboratories & Academic Institutes
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Orbital Atherectomy Device Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Orbital Atherectomy Device Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Orbital Atherectomy Device Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Orbital Atherectomy Device Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Orbital Atherectomy Device Demand Share Forecast, 2019-2026
9. North America Orbital Atherectomy Device Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Orbital Atherectomy Device Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Orbital Atherectomy Device Market Size and Volume Forecast by Application
9.4.1. Hospitals & Surgical Centers
9.4.2. Ambulatory Care Centers
9.4.3. Research Laboratories & Academic Institutes
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Orbital Atherectomy Device Market Size and Volume Forecast by Type
9.7.1. Peripheral Vascular
9.7.2. Cardiovascular
9.7.3. Neurovascular
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Orbital Atherectomy Device Demand Share Forecast, 2019-2026
10. Latin America Orbital Atherectomy Device Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Orbital Atherectomy Device Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Orbital Atherectomy Device Market Size and Volume Forecast by Application
10.4.1. Hospitals & Surgical Centers
10.4.2. Ambulatory Care Centers
10.4.3. Research Laboratories & Academic Institutes
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Orbital Atherectomy Device Market Size and Volume Forecast by Type
10.7.1. Peripheral Vascular
10.7.2. Cardiovascular
10.7.3. Neurovascular
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Orbital Atherectomy Device Demand Share Forecast, 2019-2026
11. Europe Orbital Atherectomy Device Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Orbital Atherectomy Device Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Orbital Atherectomy Device Market Size and Volume Forecast by Application
11.4.1. Hospitals & Surgical Centers
11.4.2. Ambulatory Care Centers
11.4.3. Research Laboratories & Academic Institutes
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Orbital Atherectomy Device Market Size and Volume Forecast by Type
11.7.1. Peripheral Vascular
11.7.2. Cardiovascular
11.7.3. Neurovascular
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Orbital Atherectomy Device Demand Share, 2019-2026
12. Asia Pacific Orbital Atherectomy Device Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Orbital Atherectomy Device Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Orbital Atherectomy Device Market Size and Volume Forecast by Application
12.4.1. Hospitals & Surgical Centers
12.4.2. Ambulatory Care Centers
12.4.3. Research Laboratories & Academic Institutes
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Orbital Atherectomy Device Market Size and Volume Forecast by Type
12.7.1. Peripheral Vascular
12.7.2. Cardiovascular
12.7.3. Neurovascular
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Orbital Atherectomy Device Demand Share, 2019-2026
13. Middle East & Africa Orbital Atherectomy Device Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Orbital Atherectomy Device Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Orbital Atherectomy Device Market Size and Volume Forecast by Application
13.4.1. Hospitals & Surgical Centers
13.4.2. Ambulatory Care Centers
13.4.3. Research Laboratories & Academic Institutes
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Orbital Atherectomy Device Market Size and Volume Forecast by Type
13.7.1. Peripheral Vascular
13.7.2. Cardiovascular
13.7.3. Neurovascular
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Orbital Atherectomy Device Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Orbital Atherectomy Device Market: Market Share Analysis
14.2. Orbital Atherectomy Device Distributors and Customers
14.3. Orbital Atherectomy Device Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic (Ireland)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Philips (Netherlands)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Boston Scientific (US)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cardiovascular Systems (US)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Straub Medical (Switzerland)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. BIOTRONIK (Netherlands)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. C.R. Bard (US)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Avinger (US)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
